ORIGINAL RESEARCH article
Front. Surg.
Sec. Visceral Surgery
Volume 12 - 2025 | doi: 10.3389/fsurg.2025.1636040
Impact of dexmedetomidine on Postoperative Cognitive Dysfunction and Inflammatory Response in older adult female patients undergoing laparoscopic cholecystectomy
Provisionally accepted- 1The 980 Hospital of the Joint Service Support Force of the People's Liberation Army of China, shijiazhuang, China
- 2The First Affiliated Hospital of Fujian Medical University, Fuzhou, China
- 3Hebei General Hospital, Shijiazhuang, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The aim of the present study was to identify the minimum effective dose of dexmedetomidine (Dex) that could be safely and effectively promoted for clinical application. A rigorous comparison between multiple Dex dosage groups and the control group was conducted. Based on the inclusion criteria, 165 elderly patients undergoing LC in our hospital were randomly divided into four groups: Group C ( the control group ,32 patients), group D1 ( low-dose Dex, 41 patients), group D2 ( medium -dose Dex, 49 patients), and group D3 ( high-dose Dex, 43 patients). The effects of different dose of Dex on postoperative cognitive impairment, pain scores, and inflammatory markers were subsequently studied in the selected patients. Patients who received the medium dosage of Dex experienced significantly lower incidences of postoperative agitation and tachycardia compared with the control group, and all doses of Dex reduced the incidence of Postoperative cognitive dysfunction (POCD). It was highlighted the efficacy of medium and high doses of Dex in achieving superior analgesia (as evidenced by lower VAS scores) in different postoperative time points. Concordantly, it was also revealed a similar pattern in postoperative recovery quality. After comparing the low-dose, medium-dose, and high-dose groups with the control group, we found that only the medium-dose group significantly decreased the expression levels of IL-1βand TNF-α both on the first day and second day postoperatively, while the expression levels of IL-10 increased. In conclusion,compared with normal saline, 0.6 μg/kg/h maintenance dose of Dex is the optimal dosing regimen for improving postoperative cognitive function and had a better anti-inflammation effect in elderly female patients following LC.
Keywords: Dexmedetomidine, postoperative cognitive dysfunction, inflammatory cytokines, Postoperative pain, laparoscopic cholecystectomy
Received: 27 May 2025; Accepted: 01 Oct 2025.
Copyright: © 2025 Fu, Dong, Wei, Zhao, Wang and Shi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Wenxin Shi, shiwx2017@163.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.